Announcements Trials
Browse Landscape

Phase

Phase 1 8Phase 3 5Phase 2 4Phase 1/2 2

Status

Not yet recruiting 2Completed 1Active not recruiting 1

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 3Tumor-Agnostic 1

Conditions

Breast Neoplasms 2Neoplasm Metastasis 1Advanced Breast Cancer 1

Interventions

Cisplatin 1514Carboplatin 1416Cyclophosphamide 1359Gemcitabine 1235Bevacizumab 1223Paclitaxel 1210Radiotherapy 1173Docetaxel 1079pembrolizumab 1026Oxaliplatin 934Capecitabine 898Fluorouracil 832Rituximab 729Doxorubicin 683Nivolumab 679Dexamethasone 665Etoposide 660Irinotecan 622Leucovorin 574Pemetrexed 508Drug Therapy 491Cetuximab 481Trastuzumab 467Cytarabine 466Magnetic Resonance Spectroscopy 457Filgrastim 446Prednisone 432Lenalidomide 409Specimen Handling 407Temozolomide 400

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × AZD9833 × Clear all
NCT07427394 2026-02-23

SERENA-1b

AstraZeneca

Phase 2 Not yet recruiting
24 enrolled
Breast

Advanced Breast Cancer

NCT04214288 2025-11-20

SERENA-2

AstraZeneca

Phase 2 Active not recruiting
240 enrolled 16 charts
Tumor-Agnostic

Neoplasm Metastasis

NCT07195227 2025-10-02

CADILLAC

MedSIR

Phase 2 Not yet recruiting
150 enrolled
Breast

Breast Neoplasms

NCT04588298 2025-01-24

SERENA-3

AstraZeneca

Phase 2 Completed
135 enrolled 17 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡